// App-Quantinova.ai

675 : Ninjurin1, a target of p53, modulates p53-dependent tumor suppression in vivo

Researchers

Presenter

  • Hee Jung Yang

Principal Investigators

  • Seong Jun Cho

  • Jin Zhang

  • Wensheng Yan

  • Xinbin Chen

Medical Centers

  • UC Davis, Davis, CA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Liver cancer

  • Solid malignancies

  • Sarcoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved